Macrolides in the prevention of COPD exacerbations

J. Wedzicha (London, United Kingdom)

Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Session: Non-antibiotic effects of macrolides in lung disease
Session type: Symposium
Number: 3067
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Wedzicha (London, United Kingdom). Macrolides in the prevention of COPD exacerbations. Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Corticosteroids and exacerbations of COPD
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007


Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017


Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014




Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017


Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010



Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013


Pharmacologic treatment of exacerbations of COPD
Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Year: 2016


Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019


Causes and management of exacerbations of COPD
Source: ISSN=ISSN 1810-6838, ISBN=, page=250
Year: 2007

Antibiotics in COPD exacerbations: practice and evidence
Source: Breathe 2009; 5: 299-301
Year: 2009

An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004

Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010


Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017


Exacerbations of COPD and treatment
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018


The prevention of AECOPD
Source: International Congress 2016 – The management of acute exacerbations of COPD
Year: 2016


Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010


COPD exacerbations: impact and prevention
Source: Breathe 2013; 9: 434-440
Year: 2013